Robotic technology company FBR Limited (ASX: FBR, OTCQB: FBRKF) has officially entered into an Engineering Service Agreement with Samsung Heavy Industries (SHI), marking the commencement of the first phase of a shipbuilding automation project aimed at revolutionising the global ship construction process. This agreement represents a significant milestone in FBR’s expansion into new applications for
Read More
Industry Growth Opens Doors for Pharma Innovators With the global psychedelic drugs market projected to reach A$14 billion by 2032, and the medical cannabis sector already generating more than A$3 billion annually across Australia, Germany, the UK and the EU, Bioxyne Limited (ASX:BXN) is growing revenues as it meets increased demand. The company announced an
Read More
In a move that impacts the future of wearable sensing and edge computing, Australian motion-analysis company dorsaVi (ASX:DVL) has secured exclusive worldwide rights to a transformative memory technology developed by Singapore’s Nanyang Technological University (NTU). The deal grants dorsaVi access to nine families of resistive random-access memory (RRAM) patents designed to power the next generation
Read More
Australia’s economic growth, as measured by the ABS-compiled chain volume GDP statistics that adjust for price increases, edged higher by a lower than expected 0.2 per cent in the March 2025 quarter. The accompanying ABS-prepared commentary noted that extreme weather events dampened domestic demand and reduced exports. It added that weather impacts were particularly evident
Read More
A Transformative $14 Billion Merger In a bold move that will reshape Australia’s industrial and investment sectors, Washington H. Soul Pattinson (ASX:SOL) and Brickworks (ASX:BKW) have agreed to a transformative merger that will create a new $14 billion ASX-listed entity. The deal will dismantle their long-standing cross-shareholding and replace it with a unified, more investable
Read More
TruScreen Group Limited (NZX/ASX:TRU), a medical device company focused on real-time cervical cancer screening, has raised NZ$2.35 million from a share placement that drew strong interest from investors across Asia, including some new investors from Singapore and Hong Kong. These additional funds will be used to advance the company’s AI-powered cervical cancer detection technology amid
Read More